Mitoxantrone (novantrone): a review of experimental and early clinical studies-Reference-Cited by-同舟云学术

Mitoxantrone (novantrone): a review of experimental and early clinical studies

Published:1983-06 Issue:2 Volume:10 Page:103-115
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Smith Ian E.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference64 articles.

1. Phase II cardiotoxicity study of mitoxantrone hydrochloride using exercise radionuclide evaluation of the left ventricular cardiac ejection fraction;Aapro,1982

2. Daunomycin and adriamycin: a hypothesis concerning anti-tumour activity and cardiotoxicity;Adamson;Cancer Chemother. Rep.,1974

3. Phase I clinical trial of mitoxantrone: a new anthracenedione anticancer drug;Alberts;Cancer Chemother. Pharmacol.,1980

4. Comparative pharmacology of mitoxantrone and bisantrene;Alberts,1982

5. Dihydroxyanthracenedione dihydroxychloride;American Cyanamid Company: Medical Research Division;Investigator's Brochure,1979

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Good response to CMOP regimen containing mitoxantrone hydrochloride liposome (PLM60) as induction chemotherapy in patients with angioimmunoblastic T-cell lymphoma;Frontiers in Oncology;2024-01-31

2. Current trends and challenges in the mitoxantrone measuring in biofluids and new pharmaceutical systems;TrAC Trends in Analytical Chemistry;2023-12

3. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation;Nature Communications;2023-09-18

4. Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis;Multiple Sclerosis and Related Disorders;2020-08

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

;Therapeutics and Clinical Risk Management;2020-07